NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the results of a prospective, observational study published in Critical Care in which researchers in Genoa, Italy, ...
Amsterdam, the Netherlands and Irvine, California, U.S. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Masimo (NASDAQ: MASI), a global medical technology company, ...
Now Available for Both Cerebral and Somatic Applications and for All Patient Populations, O3’s Delta Hemoglobin Parameters Offer Clinicians Additional Insight Into Changes in Tissue Oxygen Saturation ...
Irvine, Calif.-based Masimo released three clinical studies that evaluate its noninvasive patient monitoring technologies and presented them at the International Anesthesia Research Society’s Annual ...
Irvine, Calif.-based Masimo released three clinical studies that evaluate its noninvasive patient monitoring technologies and presented them at the International Anesthesia Research Society’s Annual ...
Multi-Year Partnership Renewal with Broadened Focus Will Include Expedited Technology Adoption and Market-Based Strategic Development of Next-Generation Monitoring Solutions Building on over two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback